Combination Therapy With Rituximab and Cyclophosphamide for Remission Induction in ANCA Vasculitis.

Cortazar, Frank B; Muhsin, Saif A; Pendergraft, William F; Wallace, Zachary S; Dunbar, Colleen; Laliberte, Karen; Niles, John L

Cortazar, Frank B; Muhsin, Saif A; Pendergraft, William F; Wallace, Zachary S; Dunbar, Colleen; Laliberte, Karen; Niles, John L.

Afiliación

Cortazar FB; Division of Nephrology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Muhsin SA; Vasculitis and Glomerulonephritis Center, Massachusetts General Hospital, Boston, Massachusetts, USA.
Pendergraft WF; Division of Nephrology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Wallace ZS; Center for Systems Biology, Program in Membrane Biology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Dunbar C; University of North Carolina Kidney Center, Division of Nephrology and Hypertension, Department of Medicine, Chapel Hill, North Carolina, USA.
Laliberte K; Division of Rheumatology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Niles JL; Vasculitis and Glomerulonephritis Center, Massachusetts General Hospital, Boston, Massachusetts, USA.

Kidney Int Rep ; 3(2): 394-402, 2018 Mar.

Article en En | MEDLINE | ID: mdl-29725643

Palabras clave

ANCA vasculitis; cyclophosphamide; remission; rituximab

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Kidney Int Rep Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google